TCF12 is mutated in anaplastic oligodendroglioma
2015 · Nature Communications · 70 citations
https://doi.org/10.1038/ncomms8207
M
Michel Wager
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
148
Papers
3.2K
Citations
30
h-index
53
i10-index
Michel Wager is an academic researcher from Université de Poitiers. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Meningioma and schwannoma management & Brain Metastases and Treatment. The author has an h-index of 30, co-authored 126 publications.
ORCID: 0000-0003-0782-8612Papers by this author
worksA radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells
2016 · BMC Cancer · 62 citations
https://doi.org/10.1186/s12885-016-2647-9
A mesenchymal glioma stem cell profile is related to clinical outcome
2014 · Oncogenesis · 60 citations
https://doi.org/10.1038/oncsis.2014.5
Semaphorin, neuropilin and VEGF expression in glial tumours: SEMA3G, a prognostic marker?
2008 · British Journal of Cancer · 60 citations
https://doi.org/10.1038/sj.bjc.6604641
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients
2010 · Molecular Cancer · 46 citations
https://doi.org/10.1186/1476-4598-9-234
<i><scp>EGFR</scp></i>, <i><scp>KRAS</scp></i>, <i><scp>BRAF</scp></i>, and <i><scp>HER</scp>‐2</i> molecular status in brain metastases from 77 <scp>NSCLC</scp> patients
2013 · Cancer Medicine · 36 citations
https://doi.org/10.1002/cam4.82
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat